C-08 It Ain't, But ATLAS Outcome Helps Genentech With Tarceva's NSCLC Bid
This article was originally published in The Pink Sheet Daily
Executive Summary
Combined with SATURN data, new results may enable sNDA approval in first-line maintenance without overall survival numbers.